The association of reproductive hormone levels and all-cause, cancer, and cardiovascular disease mortality in men

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 12, 2015, Pages 4472-4480

  Holmboe, Stine A ^a   Vradi, Eleni ^b   Jensen, Tina Kold ^a   Linneberg, Allan ^a,c,d   Husemoen, Lise Lotte N ^c   Scheike, Thomas ^b   Skakkebæk, Niels E ^a   Juul, Anders ^a   Andersson, Anna Maria ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Research Centre for Prevention and Health   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; DANE (PEOPLE); ESTRADIOL BLOOD LEVEL; FOLLITROPIN BLOOD LEVEL; FOLLOW UP; HUMAN; LIFE EXPECTANCY; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MIDDLE AGED; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOM SAMPLE; SMOKING; TESTOSTERONE BLOOD LEVEL; AGE; BLOOD; CARDIOVASCULAR DISEASE; EDUCATIONAL STATUS; HEALTH SURVEY; NEOPLASM;

ADULT; AGE FACTORS; AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; EDUCATIONAL STATUS; ESTRADIOL; FOLLICLE STIMULATING HORMONE, HUMAN; FOLLOW-UP STUDIES; GONADAL STEROID HORMONES; HEALTH SURVEYS; HUMANS; LIFE EXPECTANCY; LUTEINIZING HORMONE; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; SMOKING; TESTOSTERONE;

EID: 84951000212     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-2460     Document Type: Article

References (32)

1. Weinbauer GF, Luetjens CM, Simoni M, Nieschlag E. Physiology of testicular function. In: Nieschlag E, Behre HM, Nieschlag S, editors. Andrology. Philadelphia, PA: Springer; 2010:11-59.
2. Brand JS, Rovers MM, Yeap BB, et al. Testosterone, sex hormonebinding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies. PLoS One. 2014;9:e100409.
3. Araujo AB, Dixon JM, Suarez EA, Murad MH, Guey LT, Wittert GA. Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2011;96:3007-3019.
4. Tajar A, Forti G, O?Neill TW, et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab. 2010;95:1810-1818.
5. Haring R, Teng Z, Xanthakis V, et al. Association of sex steroids, gonadotrophins, and their trajectories with clinical cardiovascular disease and all-cause mortality in elderly men from the Framingham Heart Study. Clin Endocrinol (Oxf). 2013;78:629-634.
6. Phillips AC, Gale CR, Batty GD. Sex hormones and cause-specific mortality in the male veterans: the Vietnam Experience Study.QJM. 2012;105:241-246.
7. Yeap BB, Alfonso HF, Chubb SA, et al. In older men an optimal plasma testosterone is associated with reduced all-cause mortality and higher dihydrotestosterone with reduced ischemic heart disease mortality, while estradiol levels do not predict mortality. J Clin Endocrinol Metab. 2014;99:E9-E18.
8. Gerdes LU, Brønnum-Hansen H, Madsen M, et al. Trends in selected biological risk factors for cardiovascular diseases in the Danish MONICA population, 1982-1992. J Clin Epidemiol. 2000;53: 427-434.
9. Jørgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glümer C, Pisinger C. A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Eur J Cardiovasc Prev Rehabil. 2003;10:377-386.
10. Osler M, Linneberg A, Glümer C, Jørgensen T. The cohorts at the Research Centre for Prevention and Health, formerly ?The Glostrup Population Studies?. Int J Epidemiol. 2011;40:602-610.
11. Andersson AM, Jensen TK, Juul A, Petersen JH, Jørgensen T, Skakkebaek NE. Secular decline in male testosterone and sex hormone binding globulin serum levels in Danish population surveys. J Clin Endocrinol Metab. 2007;92:4696-4705.
12. Jensen TK, Andersson AM, Jorgensen N et al. Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men. Fertil Steril. 2004;82:863-870.
13. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84:3666-3672.
14. Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46:263-268.
15. Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab. 2002;87:589-598.
16. Ascoli M, Fanelli F, Segaloff DL. The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr Rev. 2002;23:141-174.
17. Andersson AM, Jørgensen N, Frydelund-Larsen L, Rajpert-De ME, Skakkebaek NE. Impaired Leydig cell function in infertile men: a study of 357 idiopathic infertile men and 318 proven fertile controls. J Clin Endocrinol Metab. 2004;89:3161-3167.
18. Jensen TK, Jacobsen R, Christensen K, Nielsen NC, Bostofte E. Good semen quality and life expectancy: a cohort study of 43,277 men. Am J Epidemiol. 2009;170:559-565.
19. Shiels MS, Rohrmann S, Menke A, et al. Association of cigarette smoking, alcohol consumption, and physical activity with sex steroid hormone levels in US men. Cancer Causes Control. 2009;20: 877-886.
20. Svartberg J, Jorde R. Endogenous testosterone levels and smoking in men. The fifth Tromsø study. Int J Androl. 2007;30:137-143.
21. Araujo AB, Kupelian V, Page ST, Handelsman DJ, Bremner WJ, McKinlay JB. Sex steroids and all-cause and cause-specific mortality in men. Arch Intern Med. 2007;167:1252-1260.
22. Barrett-Connor E, Khaw KT. Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation. 1988;78:539-545.
23. Haring R, Völzke H, Steveling A, et al.Lowserum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79. Eur Heart J. 2010;31:1494-1501.
24. Khaw KT, Dowsett M, Folkerd E, et al. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation. 2007; 116:2694-2701.
25. Laughlin GA, Barrett-Connor E, Bergstrom J. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab. 2008; 93:68-75.
26. Lin JW, Lee JK, Wu CK, et al. Metabolic syndrome, testosterone, and cardiovascular mortality in men. J Sex Med. 2011;8:2350-2360.
27. Menke A, Guallar E, Rohrmann S, et al. Sex steroid hormone concentrations and risk of death in US men. Am J Epidemiol. 2010; 171:583-592.
28. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005;28:1769-1778.
29. Brand JS, van der Tweel I, Grobbee DE, Emmelot-Vonk MH, van der Schouw YT. Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies. Int J Epidemiol. 2011;40:189-207.
30. Selva DM, Hogeveen KN, Innis SM, Hammond GL. Monosaccharide- induced lipogenesis regulates the human hepatic sex hormonebinding globulin gene. J Clin Invest. 2007;117:3979-3987.
31. Corona G, Rastrelli G, Monami M, et al. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur J Endocrinol. 2013;168:829-843.
32. Amato MC, Guarnotta V, Giordano C. Body composition assessment for the definition of cardiometabolic risk. J Endocrinol Invest. 2013;36:537-543.